Posted on 2/24/20
Raremark Partners with TriNetX
TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that Raremark, a patient . . .
Posted on 2/24/20
NeuroScience Associates and Aiforia Technologies Partner
Aiforia Technologies, an expert provider of AI solutions for image analysis, and NeuroScience Associates (NSA LabsĀ®), a leading authority in neurohistology services, announced today a collaboration . . .
Posted on 2/24/20
Dewpoint Co-Founder Anthony Hyman Wins Prestigious Wiley Prize
BOSTON--(BUSINESS WIRE)--Dewpoint Therapeutics co-founder Anthony Hyman will share the 2020 Wiley Prize in Biomedical Sciences for his foundational work on biomolecular condensates, once-mysterious cellular structures now . . .
Posted on 2/24/20
Epizyme Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing novel epigenetic therapies, today provided business and pipeline updates and reported fourth quarter . . .
Posted on 2/24/20
A Big Month Ahead for the FDA and Bristol-Myers Squibb
It's been a few months since Bristol-Myers Squibb (NYSE:BMY) completed its $74 billion purchase of Celgene, but investors still aren't sure if a couple of key . . .
Posted on 2/24/20
Thermo Fisher Scientific: Exciting Times Ahead
SummaryThermo Fisher Scientific has stitched up meaningful partnerships in 2020 that will help increase its revenues, competitiveness, and brand image.The company intends to spend $1 billion . . .
Posted on 2/24/20
BioXcel Therapeutics Prices Public Offering of Common Stock
NEW HAVEN, Conn., Feb. 20, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical development company, today announced the pricing of an underwritten . . .
Posted on 2/24/20
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
WATERTOWN, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced . . .
Posted on 2/24/20
Genprex Closes $17,500,000 Common Stock Offering
AUSTIN, Texas & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genprex, Inc. (Nasdaq: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes . . .
Posted on 2/21/20
Tufts Health Freedom Plan Expanding Virtual Health Care Globally
Tufts Health Freedom Plan announced today the expansion of its telehealth virtual health care solution. Commercial members can now access US-based, board-certified providers for general medical . . .
Posted on 2/20/20
Greentown Labs and Vineyard Wind Partnership will Support Offshore Wind Innovation
Greentown Labs, the largest cleantech incubator in North America, and Vineyard Wind, developer of the first utility-scale offshore wind energy generation facility in the Northeast United . . .
Posted on 2/20/20
Is CVS a Good Buy Right Now?
Investors were waiting with bated breath when CVS Health (NYSE:CVS) released its Q4 earnings on February 12. The company had an excellent Q3, due in no . . .
Posted on 2/20/20
Deciphera Pharmaceuticals Closes Public Offering of Common Stock
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (Nasdaq:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced the closing of its previously . . .
Posted on 2/19/20
EnClear Therapies Announces $10M Series A Financing
EnClear Therapies, a life sciences company developing device-based therapies for the treatment of neurodegenerative disease, today announced a $10 million Series A
Posted on 2/19/20
caresyntax Partners With Diversified
BOSTON--(BUSINESS WIRE)--caresyntax, a pioneer in surgical automation, quality analytics and AI software and technologies, today announced the launch of a new partnership with Diversified, an industry . . .
Posted on 2/19/20
bluebird bio Beats Its Q4 Revenue Target but Misses on EPS
bluebird bio (NASDAQ:BLUE) announced its fourth-quarter and full-year financial results on Tuesday afternoon. The clinical-stage biotech's stock price fell a bit in after-hours trading as investors . . .
Posted on 2/19/20
Affinity Dental Management Expands Footprint Into Metro New York
Affinity Dental Management, Inc., a dental services organization that provides comprehensive management and administrative support services for dental practices, has added the powerhouse dental practice, Concerned . . .
Posted on 2/18/20
Greentown Labs and Schneider Electric Launch Bold Ideas 2020 to Accelerate Energy Storage Innovations
Greentown Labs, the largest cleantech startup incubator in North America, and Schneider Electric, the global leader in the digital transformation of energy management and automation, are . . .
Posted on 2/18/20
Better Buy: Biogen vs. Bristol-Myers Squibb
You don't have to look back too far to find a time when Biogen (NASDAQ:BIIB) and Bristol-Myers Squibb (NYSE:BMY) claimed very similar market caps. That was . . .
Posted on 2/18/20
Karyopharm Therapeutics: Pullback Is Overdone
SummaryThe stock of Karyopharm Therapeutics has seen an approximate 20% pullback in recent weeks but reported solid Q4 results Thursday.We take a look at fourth-quarter numbers . . .
Posted on 2/14/20
FDA Gives Bristol-Myers Squibb's CAR-T Liso-Cel a Priority Review
The Food and Drug Administration is giving a priority review to lisocabtagene maraleucel (liso-cel), a CAR-T (chimeric antigen receptor T-cell) therapy from Bristol-Myers Squibb (NYSE:BMY). The . . .
Posted on 2/14/20
Corbus Pharmaceuticals Closes $46M Public Offering of Common Stock
Norwood, MA, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid . . .
Posted on 2/14/20
Spero Therapeutics Announces Commencement of Rights Offering
CAMBRIDGE, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in . . .
Posted on 2/14/20
Collegium Pharmaceutical Prices $125M Convertible Senior Notes Offering
STOUGHTON, Mass., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced the pricing of its offering of $125,000,000 aggregate principal amount of . . .
Posted on 2/14/20
High Focus Centers Opens New Outpatient Treatment Facility In Norwalk, CT
High Focus Centers, a Joint Commission accredited provider of outpatient behavioral healthcare treatment for individuals suffering with mental health, substance use, and eating disorders, announced today . . .

